Results of live donor liver transplantation in patients with hepatitic C virus infection: The HCV 3 trial experience

Clinical Transplantation

Volumn 26, Issue 3, 2012, Pages 502-509

  Sher, Linda ^a   Jennings, Linda ^b   Rudich, Steven ^c   Alexopoulos, Sophoclis P ^a   Netto, George ^d   Teperman, Lewis ^e   Kinkhabwala, Milan ^f   Brown, Robert S ^g   Pomfret, Elizabeth ^h   Klintmalm, Goran ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e NEW YORK UNIVERSITY   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g Columbia University College of Physicians and Surgeons ^*  (United States)

^h LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Hepatitis C; Live donor liver transplant; Liver transplantation; Outcomes; Recurrence

Indexed keywords

DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; VIRUS RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENOTYPE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTRAOPERATIVE PERIOD; LIVER BIOPSY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OPEN STUDY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; SURVIVAL RATE; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; SURVIVAL RATE; YOUNG ADULT;

EID: 84862249740     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01561.x     Document Type: Article

References (28)

1. Davis GL. Chronic hepatitis C and liver transplantation. Rev Gastroenterol Disord 2004: 4: 7.
2. Charlton M. Recurrence of hepatitis c infection: where are we now? Liver Transpl 2005: 11(Suppl 1): S57.
3. Davis GL. The challenge of progressive hepatitis C following liver transplantation. Liver Transpl 2006: 12: 19.
4. Berenguer M, Prieto M, San Juan F et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002: 36: 202.
5. Sanchez-Fueyo A, Restrepo JC, Quinto L et al. Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the grafts. Transplantation 2002: 73: 56.
6. Prieto M, Berenguer M, Rayon JM et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology 1999: 29: 250.
7. Feray C, Caccamo L, Alexander GJ et al. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology 1999: 117: 619.
8. Gane EJ, Portmann BC, Naoumov NN et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996: 334: 815.
9. Forman LM, Lewis JD, Berlin JA et al. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002: 122: 89.
10. Everson GT, Trotter J, Forman L et al. Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology 2005: 42: 255.
11. Berenguer M, Crippin J, Gish R et al. A model to predict severe HCV-related disease following liver transplantation. Hepatology 2003: 38: 34.
12. Firpi RJ, Abdelmalek MF, Soldevila-Pico C et al. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C. Liver Transpl 2004: 10: 1240.
13. Velidedeogluy E, Mange KC, Frank A et al. Factors differentially correlated with the outcome of liver transplantation in HCV+ and HCV - recipients. Transplantation 2004: 77: 1834.
14. Neumann UP, Berg T, Bahra M et al. Long-term outcome of liver transplants fo chronic hepatitis C: a 10-year follow-up. Transplantation 2004: 77: 226.
15. Garcia-Retortillo M, Forns X, Llovet JM et al. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation. Hepatology 2004: 40: 524.
16. Thuluvath PJ, Yoo HY. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation. Liver Transpl 2004: 10: 1263.
17. Kaneko J, Sugawara Y, Akamatsu N et al. Cholestatic hepatitis due to hepatitis C virus after a living donor liver transplantation. Hepatogastroenterology 2004: 51: 243.
18. Gaglio PJ, Matireddy S, Levitt BS et al. Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors. Liver Transpl 2003: 10: 1036.
19. Van Vlierberghe H, Troisi R, Colle I et al. Hepatitis C infection-related disease; patterns of recurrence and outcome in cadaveric and living-donor liver transplantation in adults. Transplantation 2004: 77: 210.
20. Russo MW, Galanko J, Beavers K et al. Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States. Liver Transpl 2004: 10: 340.
21. Bozorgzadeh A, Jain A, Ryan C et al. Impact of hepatitis C viral infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus. Transplantation 2004: 77: 1066.
22. Shiffman ML, Stravitz RT, Contos MJ et al. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation. Liver Transpl 2004: 10: 1248.
23. Takada Y, Haga H, Ito T et al. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV) positive patients. Transplantation 2006: 81: 350.
24. Guo L, Orrego M, Rodriguez-Luna H et al. Living donor liver transplantation for hepatitis C related cirrhosis: no difference in histological recurrence when compared to deceased liver transplantation recipients. Liver Transpl 2006: 12: 560.
25. Terrault NA, Shiffman ML, Lok AS et al. Outcomes of hepatitis C virus infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl 2007: 13: 122.
26. Klintmalm GB, Washburn WK, Rudich SM et al. Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 study. Liver Transpl 2007: 13: 1521.
27. Humar A, Horn A, Kalis A et al. Living donor and split-liver transplants in hepatitis D recipients: does liver regeneration increase the risk for recurrence? Am J Transplant 2005: 5: 399.
28. Selzner N, Girgrah N, Lilly L et al. The difference in fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age. Liver Transpl 2008: 14: 177.